TARIS Alternatives & Competitors

12 companies similar to TARIS — Innovative therapies for challenging bladder conditions, with a tailored, extend...

MorphoSys

Driven by our mission: More life for people with cancer.

179 IPO $3.39B

Planegg, Germany

Biotechnology Health Care

ev3

NOW PART OF MEDTRONIC. https://www.linkedin.com/company/medtronic/ Please follow us the...

281 Post Ipo Equity $34.65M

Minneapolis, United State...

Biotechnology Health Care

ARS Pharmaceuticals, Inc.

Revolutionizing treatment for severe allergic reactions with the development of a needle-f...

171 Merged $63.00M

San Diego, United States

Biopharma Health Care +1

Dyne Therapeutics

Advancing life-transforming therapies for serious muscle diseases

292 Post Ipo Equity

Waltham, United States

Biotechnology Health Care +1

Track all TARIS competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Bristol Myers Squibb

Discovery, development, licensing, manufacturing, marketing, distribution and sale of phar...

38427 IPO $22.91B

United States

Kate Therapeutics

New Hope for Patients with Muscle and Heart Disease

48 Acquired $1.17B

San Diego, United States

Biotechnology Health Care +1

Tridien Medical

Headquartered in Coral Springs, FL, Tridien develops, manufactures and markets medical dev...

53 Acquired

Developer Tools Manufacturing

Mercurial AI

Empowering providers and patients to overcome cancer with AI copilots

5 Seed $220.00K

Chicago, United States

2seventy bio

It’s about time we think smarter and faster than cancer.

122 Acquired $614.62M

Cambridge, United States

Biotechnology Health Care +1

Zenas BioPharma

Enabling patients with autoimmune diseases to reimagine life

196 Series C $318.00M

Waltham, United States

Biopharma Health Care +1

Groupe MLab

Votre santé mobilise toute notre attention.

118

Montargis, France

Health Care Internet

Roche

We advance science so that we all have more time with the people we love. Are you ready to...

108149 IPO $19.91B

Switzerland

Pharmaceutical

About TARIS

Innovative therapies for challenging bladder conditions, with a tailored, extended-release system and minimally-invasive procedures.

Services

Drug Development, Clinical Trials, Medical Device Innovation, Pharmaceutical Research

Target Customers

Patients, Healthcare Professionals, Prescribers, Caregivers, Investors

Taxonomy

Innovative Therapies, Bladder Conditions, Extended-Release System, Minimally-Invasive Procedures, Continuous Drug Delivery, TARIS Biomedical, Bladder Diseases, Customizable Drug Release, In-Office Procedures, Drug Delivery Technology, Disease Management, Targeted Treatment, Biomedical Innovation, Therapeutic Development

Business Model

B2B, B2D, B2B2C

Revenue Model

Product Sales, Licensing, Service Fee

Frequently Asked Questions

Top alternatives to TARIS include MorphoSys, ev3, ARS Pharmaceuticals, Inc., Dyne Therapeutics, Bristol Myers Squibb. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to TARIS based on industry overlap, target customers, and business model.

Innovative therapies for challenging bladder conditions, with a tailored, extended-release system and minimally-invasive procedures.

Don't just read about them. Follow them.

BounceWatch watches TARIS and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

TARIS Profile MorphoSys Alternatives ev3 Alternatives ARS Pharmaceuticals, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at TARIS on 16 Mar 2026. The 12 companies listed here were last checked between 28 Jan 2026 and 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.